Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer: methodological comment
Authors
G. Daniele
Clinical Trials Unit, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Napoli, Italy.
M. Di Maio
Clinical Trials Unit, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Napoli, Italy.
M.C. Piccirillo
Clinical Trials Unit, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Napoli, Italy.